Description
Reta-Lean (30MG) – Research Peptide
Reta-Lean (30MG) is a next-generation triple agonist peptide designed to target GLP-1, GIP, and glucagon receptors, making it one of the most advanced compounds available for metabolic research. This multi-pathway activity has positioned Reta-Lean at the forefront of studies focused on energy balance, glucose regulation, and body composition.
At Alpha X Labs, our Reta-Lean is manufactured to the highest standards, delivering exceptional purity and consistency for research applications. Each batch undergoes rigorous quality control and is lab tested to ensure accuracy and reliability.
Researchers are increasingly exploring Reta-Lean for its potential role in metabolic efficiency, appetite regulation, and enhanced energy utilization. Its extended half-life and broader receptor activity make it well-suited for advanced research protocols requiring sustained and multi-dimensional effects.
Product Specifications
Product Name: Reta-Lean
Strength: 30MG
Purity: ≥99%
Form: Lyophilized (freeze-dried) powder
Manufacturing Origin: USA
Quality Control: Independently tested with COA
Key Features
Triple agonist activity (GLP-1, GIP, and glucagon receptors)
High purity, lab-tested formulation
Manufactured in the USA
Consistent and reliable for research applications
Long-acting peptide profile
Available Sizes
Multiple vial concentrations available to support a range of research needs.
Quality Commitment
Alpha X Labs is committed to providing premium-grade compounds using advanced manufacturing processes and strict quality standards. Our focus is on precision, purity, and performance.
Important Notice
This product is strictly intended for laboratory research purposes only.
Not for human or animal consumption, medical use, diagnostic use, or therapeutic application.
Handle and store according to standard laboratory safety protocols.
